Gossamer Bio, Inc.GOSSNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+0.1%
5Y CAGR+1.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.1%/yr
vs +21.8%/yr prior
5Y CAGR
+1.2%/yr
Consistent
Acceleration
-21.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $218.97M | +25.4% |
| 2024 | $174.62M | -5.0% |
| 2023 | $183.76M | -15.9% |
| 2022 | $218.59M | +1.1% |
| 2021 | $216.12M | +4.8% |
| 2020 | $206.31M | +13.0% |
| 2019 | $182.54M | +83.8% |
| 2018 | $99.33M | +8515.3% |
| 2017 | $1.15M | +1289.2% |
| 2016 | $83000.00 | - |